Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
890.6 USD | +0.84% | -0.85% | +1.62% |
Apr. 26 | Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says | MT |
Apr. 26 | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.65% | 95.28B | |
-2.64% | 103B | |
+1.46% | 22.15B | |
-15.55% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.74% | 16.05B | |
+5.33% | 13.68B | |
+34.15% | 12.17B | |
-24.36% | 8.24B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Transcript : Regeneron Pharmaceuticals, Inc. - Shareholder/Analyst Call